17/07/2023
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2023
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
Aug »
17/07/2023
Jul 17, 2023, 18:45 |
Opinion
I aspire to be like Suresh Ramalingam - Christine Lovly
I aspire to be like Suresh S. Ramalingam. The depth and breadth of his involvement…
Jul 17, 2023, 18:18 |
Stories
Oncology, I love you, you do great, hard work, but - Kevin Hageman
Oncology, I love you, you do great, hard work, but the primary team does not…
Jul 17, 2023, 18:07 |
Societies
ESMO Members are invited to vote for the candidates running for the ESMO Nomination Committee Chair and four Member positions - ESMO
ESMO Members are invited to vote for the candidates running for the ESMO Nomination Committee Chair…
Jul 17, 2023, 17:57 |
Blog
Body image disturbances in AYA cancer patients confronting infertility risk and fertility preservation decisions - Nina Jackson Levin
Proud to share this our newest article “Body image disturbances in AYA cancer patients confronting…
Jul 17, 2023, 17:30 |
Societies
Pink Sari Inc is run by a dynamo of female community leaders from diverse language groups from the Indian sub-continent - Tracey O'Brien
One of the best parts about working at the Cancer Institute NSW is the strong partnerships with…
Jul 17, 2023, 09:59 |
Opinion
Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC - Debyani Chakravarty
My OncoKB people: Zenocutuzumab has rec’d Breakthrough Designation (BTD) from US FDA for NRG1+ NSCLC.…
Jul 17, 2023, 09:51 |
Insight
Big shout out to Conquer Cancer, the ASCO Foundation for supporting young researchers from all over the world - Akhil Santhosh
2nd ASCO merit award in 3 months.. Official announcement from ASCO breakthrough team Big shout…
Jul 17, 2023, 09:41 |
Opinion
Bereavement is likely not in the curricula for oncology fellows this July, maybe not at all over 3 years. It should be - Ramy Sedhom
Recently, I lost a pt I really liked. Surprisingly, during a brief 15 min bereavement…
Jul 17, 2023, 09:31 |
Insight
Heteroleptic bipyridine PdII-Bian complexes were cytotoxic in a low micromolar concentration range and demonstrated some selectivity toward cancer cells compared to noncancerous MRC-5 lung fibroblasts - Jemma Arakelyan
Jul 17, 2023, 07:12 |
Blog
KN495 updated clinical manuscript entitled “Biomarker-directed, pembrolizumab-based combination therapy in non-small cell lung cancer: phase 2 KEYNOTE-495/KeyImPaCT trial interim results” has been epublished by Nature Medicine on July 10
1
2
All:
13
Posts:
1 - 10
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube